B-MoGen Biotechnologies
St. Paul, US · Founded 2015 · Minnesota corporation
Find your way into B-MoGen Biotechnologies
Sign up to see every warm intro you have to B-MoGen Biotechnologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the B-MoGen Biotechnologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
B-MoGen Biotechnologies was founded in 2015 by Branden Moriarity and David Largaespada.
BM
Branden MoriarityCo-founder
DL
David LargaespadaCo-founder
KG
Kristin GeislerExecutive
JL
Jeff LiterExecutive
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2016
▶$1MraisedMay 2016 · 8 investors · BiotechnologyRule 506(b)
▶$1MraisedMay 2016 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kristin GeislerExecutive Officer
- Branden MoriarityDirector
- David LargaespadaDirector
- Jeff LiterExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1M
- First sale
- May 2016
- Incorporated
- Corporation, Minnesota, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded B-MoGen Biotechnologies?
- B-MoGen Biotechnologies was founded by Branden Moriarity, David Largaespada in 2015.
- How much funding has B-MoGen Biotechnologies raised?
- B-MoGen Biotechnologies has disclosed $1M raised across 1 round.
- Where is B-MoGen Biotechnologies headquartered?
- B-MoGen Biotechnologies is headquartered in St. Paul, US.